Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 340,700 | 376,300 | 392,100 | 413,900 | 319,600 |
Receivables | 1,309,400 | 1,337,200 | 1,315,400 | 1,316,200 | 1,319,900 |
Inventories | 855,800 | 890,400 | 915,700 | 906,700 | 845,500 |
Other current assets | 251,200 | 293,600 | 306,200 | 307,400 | 254,900 |
TOTAL | $2,757,100 | $2,897,500 | $2,929,400 | $2,944,200 | $2,739,900 |
Non-Current Assets | |||||
PPE Net | 2,544,100 | 2,558,500 | 2,548,600 | 2,553,800 | 2,647,700 |
Intangibles | 2,628,900 | 2,665,000 | 2,639,200 | 2,674,600 | 2,724,100 |
Other Non-Current Assets | 577,000 | 533,900 | 550,000 | 518,900 | 561,200 |
TOTAL | $5,750,000 | $5,757,400 | $5,737,800 | $5,747,300 | $5,933,000 |
Total Assets | $8,507,100 | $8,654,900 | $8,667,200 | $8,691,500 | $8,672,900 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 356,700 | 346,500 | 313,000 | 672,500 | 451,300 |
Accounts payable and accrued liabilities | 876,100 | 804,800 | 815,500 | 816,700 | 864,400 |
TOTAL | $2,743,000 | $2,758,400 | $2,465,200 | $3,090,800 | $2,730,700 |
Non-Current Liabilities | |||||
Long Term Debt | 2,918,000 | 3,017,200 | 3,455,100 | 2,969,900 | 3,089,500 |
aiOther Non-Current Liabilities | 941,300 | 1,045,700 | 1,056,000 | 1,105,700 | 1,097,700 |
TOTAL | $4,414,000 | $4,593,800 | $5,007,100 | $4,585,700 | $4,696,800 |
Total Liabilities | $7,157,000 | $7,352,200 | $7,472,300 | $7,676,500 | $7,427,500 |
Shareholders' Equity | |||||
Shares Outstanding, K | 1,030,713 | 1,036,110 | 1,038,852 | 1,046,357 | 1,050,430 |
Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
Retained earnings | 8,968,100 | 8,771,000 | 8,575,700 | 8,244,200 | 8,223,900 |
Other shareholders' equity | -2,088,000 | -2,047,000 | -2,077,100 | -2,128,000 | -2,114,200 |
TOTAL | $1,350,100 | $1,302,700 | $1,194,900 | $1,015,000 | $1,245,400 |
Total Liabilities And Equity | $8,507,100 | $8,654,900 | $8,667,200 | $8,691,500 | $8,672,900 |